<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>PrescriptionUpdates.com</title>
	<atom:link href="http://prescriptionupdates.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://prescriptionupdates.wordpress.com</link>
	<description></description>
	<lastBuildDate>Thu, 13 Dec 2007 06:04:30 +0000</lastBuildDate>
	<generator>http://wordpress.com/</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<cloud domain='prescriptionupdates.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://www.gravatar.com/blavatar/bb48811cea19ef36f5dd214c92473064?s=96&#038;d=http://s.wordpress.com/i/buttonw-com.png</url>
		<title>PrescriptionUpdates.com</title>
		<link>http://prescriptionupdates.wordpress.com</link>
	</image>
			<item>
		<title>Desmopressin Acetate (marketed as DDAVP Nasal Spray, DDAVP Rhinal Tube, DDAVP, DDVP, Minirin, and Stimate Nasal Spray)</title>
		<link>http://prescriptionupdates.wordpress.com/2007/12/13/desmopressin-acetate-marketed-as-ddavp-nasal-spray-ddavp-rhinal-tube-ddavp-ddvp-minirin-and-stimate-nasal-spray/</link>
		<comments>http://prescriptionupdates.wordpress.com/2007/12/13/desmopressin-acetate-marketed-as-ddavp-nasal-spray-ddavp-rhinal-tube-ddavp-ddvp-minirin-and-stimate-nasal-spray/#comments</comments>
		<pubDate>Thu, 13 Dec 2007 06:03:01 +0000</pubDate>
		<dc:creator>MarkS</dc:creator>
				<category><![CDATA[Desmpressin Acetate]]></category>
		<category><![CDATA[DDAVP]]></category>
		<category><![CDATA[DDAVP Nasal Spray]]></category>
		<category><![CDATA[DDAVP Rhinal Tube]]></category>
		<category><![CDATA[DDVP]]></category>
		<category><![CDATA[Desmopressin Acetate]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Minirin]]></category>
		<category><![CDATA[Stimate Nasal Spray]]></category>

		<guid isPermaLink="false">http://prescriptionupdates.wordpress.com/2007/12/13/desmopressin-acetate-marketed-as-ddavp-nasal-spray-ddavp-rhinal-tube-ddavp-ddvp-minirin-and-stimate-nasal-spray/</guid>
		<description><![CDATA[
FDA notified healthcare professionals and patients of the Agency&#8217;s request that manufacturers update the prescribing information for desmopressin to include important new safety information about severe hyponatremia and seizures. Certain patients, including children treated with the intranasal formulation of the drug for primary nocturnal enuresis (PNE), are at risk for developing severe hyponatremia that can [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prescriptionupdates.wordpress.com&blog=1694200&post=8&subd=prescriptionupdates&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://prescriptionupdates.wordpress.com/2007/12/13/desmopressin-acetate-marketed-as-ddavp-nasal-spray-ddavp-rhinal-tube-ddavp-ddvp-minirin-and-stimate-nasal-spray/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/841e24dc28579bd5d7e4c2390f4c821d?s=96&#38;d=identicon" medium="image">
			<media:title type="html">MarkS</media:title>
		</media:content>
	</item>
		<item>
		<title>CellCept (mycophenolate mofetil)</title>
		<link>http://prescriptionupdates.wordpress.com/2007/12/13/cellcept-mycophenolate-mofetil/</link>
		<comments>http://prescriptionupdates.wordpress.com/2007/12/13/cellcept-mycophenolate-mofetil/#comments</comments>
		<pubDate>Thu, 13 Dec 2007 06:00:49 +0000</pubDate>
		<dc:creator>MarkS</dc:creator>
				<category><![CDATA[CellCept]]></category>
		<category><![CDATA[Birth Defects]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Mycophenolic Acid]]></category>

		<guid isPermaLink="false">http://prescriptionupdates.wordpress.com/2007/12/13/cellcept-mycophenolate-mofetil/</guid>
		<description><![CDATA[
Prescribing information for Mycophenolic Acid (marketed as Myfortic Delayed Released Tablets) revised to include information that use of drug during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. 
 
Roche and FDA notified healthcare providers that use of CellCept (mycophenolate mofetil) is associated with increased risk of first trimester pregnancy loss and increased [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prescriptionupdates.wordpress.com&blog=1694200&post=7&subd=prescriptionupdates&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://prescriptionupdates.wordpress.com/2007/12/13/cellcept-mycophenolate-mofetil/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/841e24dc28579bd5d7e4c2390f4c821d?s=96&#38;d=identicon" medium="image">
			<media:title type="html">MarkS</media:title>
		</media:content>
	</item>
		<item>
		<title>Byetta (exenatide)</title>
		<link>http://prescriptionupdates.wordpress.com/2007/12/12/byetta-exenatide/</link>
		<comments>http://prescriptionupdates.wordpress.com/2007/12/12/byetta-exenatide/#comments</comments>
		<pubDate>Wed, 12 Dec 2007 03:38:58 +0000</pubDate>
		<dc:creator>MarkS</dc:creator>
				<category><![CDATA[Byetta]]></category>
		<category><![CDATA[Abdominal Pain]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Pancreatitis]]></category>

		<guid isPermaLink="false">http://prescriptionupdates.wordpress.com/2007/12/12/byetta-exenatide/</guid>
		<description><![CDATA[FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta (exenatide), a drug used to treat adults with type 2 diabetes. An association between Byetta and acute pancreatitis is suspected in some of these cases. Amylin Pharmaceuticals, Inc. has agreed to include information about acute pancreatitis in the PRECAUTIONS section of the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prescriptionupdates.wordpress.com&blog=1694200&post=6&subd=prescriptionupdates&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://prescriptionupdates.wordpress.com/2007/12/12/byetta-exenatide/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/841e24dc28579bd5d7e4c2390f4c821d?s=96&#38;d=identicon" medium="image">
			<media:title type="html">MarkS</media:title>
		</media:content>
	</item>
		<item>
		<title>Trasylol (aprotinin injection)</title>
		<link>http://prescriptionupdates.wordpress.com/2007/12/12/trasylol-aprotinin-injection/</link>
		<comments>http://prescriptionupdates.wordpress.com/2007/12/12/trasylol-aprotinin-injection/#comments</comments>
		<pubDate>Wed, 12 Dec 2007 03:24:08 +0000</pubDate>
		<dc:creator>MarkS</dc:creator>
				<category><![CDATA[Trasylol]]></category>
		<category><![CDATA[Bypass Surgery]]></category>
		<category><![CDATA[Cardiac]]></category>
		<category><![CDATA[Death]]></category>

		<guid isPermaLink="false">http://prescriptionupdates.wordpress.com/2007/12/12/trasylol-aprotinin-injection/</guid>
		<description><![CDATA[ 
FDA announced that, at the agency&#8217;s request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol (aprotinin injection), a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death. FDA requested the suspension in the interest of [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prescriptionupdates.wordpress.com&blog=1694200&post=5&subd=prescriptionupdates&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://prescriptionupdates.wordpress.com/2007/12/12/trasylol-aprotinin-injection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/841e24dc28579bd5d7e4c2390f4c821d?s=96&#38;d=identicon" medium="image">
			<media:title type="html">MarkS</media:title>
		</media:content>
	</item>
		<item>
		<title>Avandia (rosiglitazone maleate) Tablets</title>
		<link>http://prescriptionupdates.wordpress.com/2007/12/12/avandia-rosiglitazone-maleate-tablets/</link>
		<comments>http://prescriptionupdates.wordpress.com/2007/12/12/avandia-rosiglitazone-maleate-tablets/#comments</comments>
		<pubDate>Wed, 12 Dec 2007 03:20:18 +0000</pubDate>
		<dc:creator>MarkS</dc:creator>
				<category><![CDATA[Avandia]]></category>
		<category><![CDATA[Black Box]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Heart Attacks]]></category>
		<category><![CDATA[Warnings]]></category>

		<guid isPermaLink="false">http://prescriptionupdates.wordpress.com/2007/12/12/avandia-rosiglitazone-maleate-tablets/</guid>
		<description><![CDATA[
FDA informed healthcare professionals of new information added to the existing boxed warning in Avandia&#8217;s prescribing information about potential increased risk for heart attacks. The new information refers to a meta-analysis of 42 clinical studies, most of which compared Avandia to placebo, that showed Avandia to be associated with an increased risk of myocardial ischemic [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prescriptionupdates.wordpress.com&blog=1694200&post=4&subd=prescriptionupdates&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://prescriptionupdates.wordpress.com/2007/12/12/avandia-rosiglitazone-maleate-tablets/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/841e24dc28579bd5d7e4c2390f4c821d?s=96&#38;d=identicon" medium="image">
			<media:title type="html">MarkS</media:title>
		</media:content>
	</item>
	</channel>
</rss>